Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells

被引:72
作者
Husain, Islam [1 ]
Sharma, Anjana [1 ]
Kumar, Suresh [2 ]
Malik, Fayaz [2 ]
机构
[1] Rani Durgavati Univ, Dept PG Studies & Res Biol Sci, Bacteriol Lab, Jabalpur, Madhya Pradesh, India
[2] Indian Inst Integrat Med, Canc Pharmacol Div, Jammu, India
来源
PLOS ONE | 2016年 / 11卷 / 02期
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; EXTRACELLULAR L-ASPARAGINASE; ESCHERICHIA-COLI; CANCER; ELECTROPHORESIS; APOPTOSIS; CLEAVAGE; SERUM; YEAST; VIVO;
D O I
10.1371/journal.pone.0148877
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Asparaginase is an important antileukemic agent extensively used worldwide but the intrinsic glutaminase activity of this enzymatic drug is responsible for serious life threatening side effects. Hence, glutaminase free asparaginase is much needed for upgradation of therapeutic index of asparaginase therapy. In the present study, glutaminase free asparaginase produced from Enterobacter cloacae was purified to apparent homogeneity. The purified enzyme was found to be homodimer of approximately 106 kDa with monomeric size of approximately 52 kDa and p/ 4.5. Purified enzyme showed optimum activity between pH 7-8 and temperature 35-40 degrees C, which is close to the internal environment of human body. Monovalent cations such as Na+ and K+ enhanced asparaginase activity whereas divalent and trivalent cations, Ca2+, Mg2+, Zn2+, Mn2+, and Fe3+ inhibited the enzyme activity. Kinetic parameters K-m, V-max and K-cat of purified enzyme were found to be 1.58x10(-3) M, 2.22 IU mu g(-1) and 5.3 x 10(4) S-1, respectively. Purified enzyme showed prolonged in vitro serum (T-1/2 = similar to 39 h) and trypsin (T-1/2 = similar to 32min) half life, which is therapeutically remarkable feature. The cytotoxic activity of enzyme was examined against a panel of human cancer cell lines, HL-60, MOLT-4, MDA-MB-231 and T47D, and highest cytotoxicity observed against HL-60 cells (IC50 similar to 3.1 IU ml(-1)), which was comparable to commercial asparaginase. Cell and nuclear morphological studies of HL-60 cells showed that on treatment with purified asparaginase symptoms of apoptosis were increased in dose dependent manner. Cell cycle progression analysis indicates that enzyme induces apoptosis by cell cycle arrest in G0/G1 phase. Mitochondrial membrane potential loss showed that enzyme also triggers the mitochondrial pathway of apoptosis. Furthermore, the enzyme was found to be nontoxic for human noncancerous cells FR-2 and non-hemolytic for human erythrocytes.
引用
收藏
页数:27
相关论文
共 58 条
  • [1] [Anonymous], INT J PHARM BIO SC B
  • [2] [Anonymous], 2015, Int J Curr Microbiol. Appl. Sci.
  • [3] ASSELIN BL, 1989, CANCER RES, V49, P4363
  • [4] A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:: a Children's Cancer Group study
    Avramis, VI
    Sencer, S
    Periclou, AP
    Sather, H
    Bostrom, BC
    Cohen, LJ
    Ettinger, AG
    Ettinger, LJ
    Franklin, J
    Gaynon, PS
    Hilden, JM
    Lange, B
    Majlessipour, F
    Mathew, P
    Needle, M
    Neglia, J
    Reaman, G
    Holcenberg, JS
    [J]. BLOOD, 2002, 99 (06) : 1986 - 1994
  • [5] Structural stability and functional analysis of L-asparaginase from Pyrococcus furiosus
    Bansal, S.
    Gnaneswari, D.
    Mishra, P.
    Kundu, B.
    [J]. BIOCHEMISTRY-MOSCOW, 2010, 75 (03) : 375 - 381
  • [6] BROOME JD, 1965, JNCI-J NATL CANCER I, V35, P967
  • [8] A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs
    Bulmus, V
    Woodward, M
    Lin, L
    Murthy, N
    Stayton, P
    Hoffman, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 93 (02) : 105 - 120
  • [9] The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells
    Chan, Wai Kin
    Lorenzi, Philip L.
    Anishkin, Andriy
    Purwaha, Preeti
    Rogers, David M.
    Sukharev, Sergei
    Rempe, Susan B.
    Weinstein, John N.
    [J]. BLOOD, 2014, 123 (23) : 3596 - 3606
  • [10] Targeting apoptotic pathways in cancer cells
    Denicourt, C
    Dowdy, SF
    [J]. SCIENCE, 2004, 305 (5689) : 1411 - 1413